Eslami, M.; Safaripour, A.; Banihashemian, S.Z.; Nikjoo Niaragh, S.; Hemmati, M.A.; Shojaeian, A.; Fakhariyan, S.; Rabbani, A.; Oksenych, V.
Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies. Microorganisms 2025, 13, 295.
https://doi.org/10.3390/microorganisms13020295
AMA Style
Eslami M, Safaripour A, Banihashemian SZ, Nikjoo Niaragh S, Hemmati MA, Shojaeian A, Fakhariyan S, Rabbani A, Oksenych V.
Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies. Microorganisms. 2025; 13(2):295.
https://doi.org/10.3390/microorganisms13020295
Chicago/Turabian Style
Eslami, Majid, Amirabbas Safaripour, Seyedeh Zahra Banihashemian, Sahar Nikjoo Niaragh, Mohammad Amin Hemmati, Arefeh Shojaeian, Setayesh Fakhariyan, Atiye Rabbani, and Valentyn Oksenych.
2025. "Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies" Microorganisms 13, no. 2: 295.
https://doi.org/10.3390/microorganisms13020295
APA Style
Eslami, M., Safaripour, A., Banihashemian, S. Z., Nikjoo Niaragh, S., Hemmati, M. A., Shojaeian, A., Fakhariyan, S., Rabbani, A., & Oksenych, V.
(2025). Innovative Antibiotic Therapies for Carbapenem-Resistant Gram-Negative Bacterial Infections: Clinical Efficacy, Safety, and Comparative Studies. Microorganisms, 13(2), 295.
https://doi.org/10.3390/microorganisms13020295
